THE ROLE OF BubR1 IN MITOSIS
============================

BubR1 is an orthologue of yeast Mad3 that binds and inhibits the multisubunit E3 ligase APC/C in SAC signaling ([@b7-molcell-37-10-713]; [@b46-molcell-37-10-713]). As illustrated in [Fig. 1](#f1-molcell-37-10-713){ref-type="fig"}, human BubR1 is ∼125 kDa protein, composed of 1,050 amino acids. Yeast Mad3 and mammalian BubR1 share homology at the N-terminus: TPR (tetratricopeptide repeat) domain is required for recruitment to kinetochore by binding to Blinkin/KNL1 ([@b23-molcell-37-10-713]; [@b24-molcell-37-10-713]). KNL1 is a core component of KMN network, essential for kinetochore-microtubule interaction for chromosome alignment ([@b44-molcell-37-10-713]; [@b50-molcell-37-10-713]); GLEBS (Gle-2-binding sequence) motif is for Bub3 binding ([@b29-molcell-37-10-713]); KEN boxes and D-box found in mammalian BubR1 are the degrons required for binding to Cdc20 and APC/C ([@b5-molcell-37-10-713]; [@b28-molcell-37-10-713]; [@b48-molcell-37-10-713]).

Unlike yeast Mad3, mammalian BubR1 has kinase domain similar to Bub1 at the C-terminus ([Fig. 1](#f1-molcell-37-10-713){ref-type="fig"}). For a number of years, significant efforts were made to reveal the substrates of BubR1 kinase. An interesting idea was that CENP-E, the plus end-directed microtubule motor, binds to BubR1 and activates the kinase activity for BubR1 ([@b31-molcell-37-10-713]; [@b32-molcell-37-10-713]). However, numerous following works failed to confirm the kinase activity of BubR1. Recently, it was suggested that the C-terminal kinase domain of BubR1 is a pseudo-kinase domain, resulting from the amplification from Bub1, and thus BubR1 does not possess any kinase activity ([@b42-molcell-37-10-713]).

Mitotic kinases such as CDK1, Plk1, and Aurora B phosphorylate BubR1 at distinct sites. The outcome of the phosphorylation at each site is not fully understood, but is expected to be crucial in mitotic checkpoint signaling. BubR1 has two distinct functions in mitosis: regulation of chromosome congression and SAC ([@b14-molcell-37-10-713]). Phosphorylation of BubR1 at serines and threnines of T680, T620, D670, D676, T680 are involved in tension sensing, kinetochore-microtubule interaction, and mitotic exit ([@b13-molcell-37-10-713]; [@b14-molcell-37-10-713]; [@b17-molcell-37-10-713]; [@b42-molcell-37-10-713]). Comparing the structure of yeast Mad3 with mammalian BubR1, it appears that the spindle checkpoint regulation may be a more ancient function and the role in the stabilization of kinetochore-microtubule attachment has evolved in vertebrates ([Fig. 1](#f1-molcell-37-10-713){ref-type="fig"}). Apparently, the KARD domain, constituted of many Plk1-mediated phosphorylation sites are required for binding to PP2A-B56α, counteracting the excessive Aurora B kinase activity for chromosome alignment in metaphase ([@b25-molcell-37-10-713]; [@b42-molcell-37-10-713]).

BubR1 IN SAC ACTIVATION, MAINTENANCE, AND SILENCING
===================================================

Treatment of microtubule poisons result in hyperphosphorylation of BubR1, indicating that phosphorylations at multiple sites are important in exhibiting mitotic functions of BubR1. In addition to phosphorylation, BubR1 is acetylated at lysine 250 in prometaphase ([@b9-molcell-37-10-713]). Acetylated BubR1 functions as an inhibitor of APC/C and the deacetylated BubR1 becomes the substrate of APC/C. Polyubiquitination and subsequent degradation of deacetylated BubR1 are followed by cyclin B destruction, leading to anaphase onset and mitotic exit. When acetylationmimetic mutant of BubR1 is expressed, it blocks the anaphase onset. On the contrary, the expression of acetylation-deficient form allows shortening of mitotic timing with unequal chromosome segregation. The result indicates that acetylation/deacetylation of BubR1 determines the mitotic timing and modulates APC/C activity. Thus, BubR1 acetylation is a crucial part of SAC signaling ([@b9-molcell-37-10-713]).

SAC activity can be divided into two phases: SAC signal generation and maintenance of SAC. First, Mad1 and Mad2 are recruited to unattached kinetochores. Then, Mad2 undergoes conformational change from open Mad2 (O-Mad2) to closed Mad2 (C-Mad2). C-Mad2 then binds to Cdc20, promoting the mitotic checkpoint complex (MCC) formation ([@b35-molcell-37-10-713]), composed of Mad2, BubR1, Bub3, Cdc20. It is now known that Mad2 only loads Cdc20 to BubR1 and BubR1 is the true inhibitor for APC/C-Cdc20 ([@b16-molcell-37-10-713]; [@b36-molcell-37-10-713]). MCC formation is thought to be the key to sustain SAC by titrating out Cdc20 from APC/C ([@b35-molcell-37-10-713]; [@b40-molcell-37-10-713]), and also continuously ubiquitinating and degrading Cdc20 when SAC is on ([@b36-molcell-37-10-713]). Thus, MCC disassembly is crucial in checkpoint silencing.

Progress has been made recently on the understanding of how MCC disassembly is promoted, leading to checkpoint silencing. APC15, one of the components of APC/C mediates the autoubiquitination of cdc20, resulting in the degradation and disassembly of MCC ([@b15-molcell-37-10-713]; [@b30-molcell-37-10-713]; [@b49-molcell-37-10-713]).

Deacetylation of BubR1 ([@b9-molcell-37-10-713]) leads to ubiquitination by APC/C and degradation of it, thus can also participate in the disassembly of MCC. Indeed, it was shown that cells isolated from the mouse heterozygous of acetylation-deficient allele (*K243R/+*) failed to retain MCC upon nocodazole treatment, whereas the checkpoint signal generation, measured by Mad1/Mad2 localization at unattached kinetochores were intact. These results suggest that the early onset destruction of acetylation-deficient BubR1 may serve as the cue to disassembly of MCC ([@b38-molcell-37-10-713]), and checkpoint silencing.

The role of p31^comet^ has been identified in SAC silencing: it binds to C-Mad2-Cdc20 complex, thereby titrating out Mad2, promoting the disassembly of MCC ([@b34-molcell-37-10-713]; [@b47-molcell-37-10-713]; [@b54-molcell-37-10-713]; [@b58-molcell-37-10-713]). However, an elegant biochemical study have shown that it is BubR1-Cdc20 complex that truly inhibits APC/C activity, and extracting Mad2 from the complex does not inhibit APC/C to a potent level, suggesting that the role of p31^comet^ in SAC silencing may be secondary in SAC silencing ([@b16-molcell-37-10-713]).

FUNCTIONS OF BubR1 IN CHROMOSOME-SPINDLE ATTACHMENT
===================================================

Loss of BubR1 results in the failure of the stable maintenance of chromosome-spindle attachment ([@b27-molcell-37-10-713]). Loss of CENP-E, the plus end-directed motor protein that binds to BubR1 at kinetochore, leads to the increase of monotelic chromosomes near the pole ([@b20-molcell-37-10-713]). When compared to the loss of CENP-E, BubR1 loss leads to a more profound defects in chromosome congression, indicating a direct role of BubR1 in kinetochore-microtubule (KT-MT) interaction than CENP-E. Furthermore, impaired kinetochore-microtubule attachment is restored in BubR1-depleted cells when Aurora B activity is inhibited, suggesting that BubR1 antagonizes Aurora B's activity in KT-MT attachment ([@b27-molcell-37-10-713]).

Erroneous microtubule attachment is corrected by the activity of Aurora B. Located at the inner kinetochore, Aurora B phosphorylates multiprotein complexes at the outer kinetochore, the KMN network (KNL1-Mis12-Ndc80) and Sca1-Dam complexes, destabilizing the kinetochore-microtubule attachments ([@b6-molcell-37-10-713]; [@b8-molcell-37-10-713]; [@b53-molcell-37-10-713]). Once amphitelic attachment is achieved, Aurora B activity must be counteracted to stabilize KT-MT attachment and chromosome alignment at the metaphase plate (congression). In brief, KT-MT attachment and SAC are well harmonized in mitosis by the activity of Aurora B: SAC is on when chromosomes are not attached to microtubules in a bipolar manner (Aurora B active); and turns off when chromosomes-spindle attachment is satisfied (Aurora B inactive). Therefore, phosphatases PP1 ([@b22-molcell-37-10-713]) and PP2A ([@b45-molcell-37-10-713]) have been suggested to antagonize activity of Aurora B to promote chromosome congression.

BubR1 recruits B56α subunit of PP2A to the kinetochore, contributing to stable KT-MT attachment ([@b26-molcell-37-10-713]; [@b43-molcell-37-10-713]). Notably, tension-sensitive phosphorylations by Plk1 at the KARD domain (S670, S676, T680) are required for binding PP2A-B56α to BubR1 at kinetochore ([Fig. 1](#f1-molcell-37-10-713){ref-type="fig"}). PP2A activity at the kinetochore antagonizes the excessive activity of Aurora B in disassembly of microtubules at the kinetochore, thus stabilizing KT-MT attachments and achieving chromosome congression ([@b26-molcell-37-10-713]; [@b43-molcell-37-10-713]; [@b57-molcell-37-10-713]). Collectively, BubR1 links KT-MT attachment to SAC signaling.

BubR1 acetylation at K250 is also required for recruiting PP2A-B56α to the kinetochore. Interaction between BubR1 and PP2A-B56α is acetylation-dependent, and cells isolated from the mice heterozygous for acetylation-deficient BubR1 (*K243R/+*) exhibit severe problems in chromosome congression ([@b38-molcell-37-10-713]). How acetylation at K250 is coordinated with Plk1's phosphorylation at KARD domain is not known. Nevertheless, the result suggests an interesting hypothesis that there may be an acetylation-phosphorylation code in sensing KT-MT attachments to SAC signaling, and finally to SAC silencing.

*BubR1* MUTATION IN HUMAN DISEASE
=================================

Mosaic Variegated Aneuploidy (MVA) and/or Premature chromatid separation (PCS) are rare genetic disorders that display aneuploidy and premature sister chromatid separations (PMSC) in metaphase chromosome spreads. MVA patients are characterized by severe microcephaly, growth defects, mental retardation, and neoplasia ([@b18-molcell-37-10-713]; [@b21-molcell-37-10-713]; [@b33-molcell-37-10-713]).

Notably, BubR1 mutation is associated with MVA with cancer predisposition ([@b11-molcell-37-10-713]; [@b41-molcell-37-10-713]). However, it is unclear whether specific mutations are linked with distinct phenotypes in MVA of heterologous symptoms. Taken together with the BubR1 mutations found in somatic cancers ([@b2-molcell-37-10-713]), it is noteworthy that dysfunctional BubR1 contributes to tumorigenesis.

BubR1 MOUSE MODELS IN CANCER PREDISPOSITION
===========================================

Despite the frequent aneuploidy in human cancers, mutations in SAC genes are rare. The reason for this may be that SAC is essential in cell proliferation, therefore is detrimental when deleted. Indeed, homozygous deletions of genes coding for *Mad2* ([@b12-molcell-37-10-713]), *Bub1* ([@b19-molcell-37-10-713]), *BubR1* (Wang et al., 2004) in mice exhibit early embryonic lethality, indicating that severe mitotic failure are indeed detrimental.

Mice knockout of *BubR1* allele are lethal in early embryonic stage; heterozygous mice are viable and display megakaryopoiesis with aneuploidy but not spontaneous cancers (Wang et al., 2004). Paradoxically, gradual reduction of BubR1 level in mice of hypomorphic *BubR1* allele exhibit senescence and premature aging but not spontaneous cancer ([@b1-molcell-37-10-713]). Apparently, both haploinsufficient (Wang et al., 2004) and hypomorphic *BubR1* allele display aneuploidy, indicating that aneuploidy alone does not impose on tumorigenesis. Notably, mice heterozygous of *CENPE*-null allele ([@b52-molcell-37-10-713]) imply that aneuploidy can be oncogenic to a certain degree, but is tumor suppressive when combined with more genetic insults. Indeed, aneuploidy in mammalian cells induce proliferation defects and metabolic abnormalities, suggesting that the burden of having to produce too much nucleic acids and proteins are toxic to cellular fitness ([@b56-molcell-37-10-713]), consistent with the phenotypes observed from Down's syndrome ([Table 1](#t1-molcell-37-10-713){ref-type="table"}).

However, when *BubR1* haploinsufficient mice are crossed to *APC^Min/+^* mice, tumorigenesis in the large intestine increases to ten-fold, with the decrease of the polyps in the small intestines ([@b39-molcell-37-10-713]), suggesting that there is more than aneuploidy in *BubR1* mutation, compared to *CENP-E* haploinsufficiency. It is worth mentioning that the depletion of BubR1 has far more profound effects in chromosome congression, compared to CENPE depletion, as mentioned above ([@b27-molcell-37-10-713]).

Reduction of BubR1 protein level predisposes to early onset aging in mice ([@b1-molcell-37-10-713]), which is also observed in the monoallelic insertional mutation of *BubR1* at nucleotide 2118 position ([@b55-molcell-37-10-713]). This allale (*BubR1^GTTA/+^*) was created after the genetic mutation in one of the MVA patients. However, the mutation lies after the KARD domain ([Fig. 1](#f1-molcell-37-10-713){ref-type="fig"}) and affects the C-terminus pseudokinase domain, which might not have crucial functions in SAC. Nevertheless, *BubR1^H/H^* and *BubR1^GTTA/+^* mice links *BubR1* mutation with aging-related MVA phenotype, albeit the absence of tumor formation (Summarized in [Table 1](#t1-molcell-37-10-713){ref-type="table"}).

Notably, cancer predisposition is observed in mice heterozygous of acetylation-deficient *BubR1* allele (K243R/+): *K243R/+* mice are succumbed to high incidence of spontaneous tumorigenesis, most abundantly lymphoma ([@b38-molcell-37-10-713]). In fact, this is the first mouse model to show that a single mutation in SAC components can lead to high-incidence spontaneous tumorigenesis.

It is important to speculate the difference of *K243R/+* mice from those of other *BubR1* mouse models in cancer predisposition. Critical difference may rely on the fact that acetylation of K250 (K243 in mice) has dual roles: one in stable chromosome-spindle attachment and the other in the stable maintenance of MCC until checkpoint is satisfied. Homozygous mutations are detrimental that it exhibits embryonic lethality at embryonic day 6, even before the homozygous deletion of BubR1 allele ([Table 1](#t1-molcell-37-10-713){ref-type="table"}).

In K243R/+ heterozygous cells, the wild-type and mutant protein co-exist in 1:1 ratio; K243R protein localizes to the kinetochore as much as the wild-type BubR1 does, inhibiting the recruitment of PP2A-B56α to kinetochores, thus *K243R* allele is a dominant negative allele. In comparison, BubR1 in *BubR1^+/^*^−^ cells localized more to the kinetochores with the decrease of the cytosolic portion, therefore the defect was not as severe as *K243R/+*, explaining the absence of spontaneous tumorigenesis in *BubR1^+/^*^−^ mice. It is worth mentioning that the acetylation of BubR1 at K250 requires BRCA2, hence BubR1 acetylation is a tumor suppressive mechanism ([@b10-molcell-37-10-713]). *K243R/+* mice represent the *BRCA2*-deficiency in mitotic failure and tumorigeneis.

CONCLUSION
==========

What makes *K243R/+* mice tumor-prone and others don't? It is conceivable to think that the massive chromosome missegregation resulting from the combined effects of failure in KTMT attachment and weakened SAC instigated genetic instability, thus cancer, in K243R/+ mice. As observed from *BubR1* haploinsufficiency, cells try to cope with the reduced level of BubR1 in mitosis. However, the aging phenotypes in hypomorphic *BubR1* mouse and the *BubR1^GTTA/+^* mice suggest that reduced level of BubR1 may have effects in interphase, leading to senescence and aging.

Recently, it was shown that BubR1 acetylation status modulates the outgrowth of dendrite in neuronal cells ([@b51-molcell-37-10-713]) and also the lifespan ([@b37-molcell-37-10-713]), indicating that BubR1 has many more functions than unerstood. Nevertheless, lessons from *K243R/+* mice indicate that BubR1 mutations linked with its critical functions in mitosis can predispose to tumorigenesis. It will be important to assign different human genetic mutations with different functions of BubR1.
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###### 

Different *BubR1* mouse models and their characteristics

  Strategy                                                                                                                                                   Allele                                                                                                                                                                   Phenotype                                                                                                                                                                                                               Reference
  ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------
  Targeted disruption of the *BubR1* locus between exon 1 and 2 by gene-trapping method                                                                      *BubR1*^−^*^/^* ^−^                                                                                                                                                      Failed to survive beyond day 8.5 in utero as a result of extensive apoptosis                                                                                                                                            
  *BubR1^+/^*^−^                                                                                                                                             -Splenomegaly and abnormal megakaryopoiesis coupled with decreased erythropoiesis-When challenged with azoxymethane (AOM), develop lung and intestinal adenocarcinomas   Wang et al., 2004                                                                                                                                                                                                       
  *BubR1*^+/−^ *;Apc^Min/+^*                                                                                                                                 Develops ten-times more colonic tumor masses than *ApcMin/+* with higher grade polyps; yet fewer polyps in small intestines.                                             [@b39-molcell-37-10-713]                                                                                                                                                                                                
  Hypomophic *BubR1* expression: The mutant allele was engineered to generate abnormal splicing. The resulting mutant mRNA cannot produce *BubR1* protein.   *Bub1b^H/H^*                                                                                                                                                             -Aneuploidy-Features of aging: short lifespan, cachectic dwarf-ism, lordokyphosis, cataracts, loss of subcutaneous fat and impaired wound healing-Infertile-No spontaneous tumorigenesis                                [@b1-molcell-37-10-713]
  Homologous Recombination mediated insertion of GTTA squence in the murine *BubR1* gene at position 2178                                                    *BubR1^GTTA/+^*                                                                                                                                                          -Mimics nonsense mutation 2211insGTTA found in MVA patients-Mild aneuploidy-Reduced life span and carry age-related phenotypes: loss of skeletal muscle and fat-Increased incidence of lung tumor upon DMBA treatment   [@b55-molcell-37-10-713]
  Substitution of acetylation site K243 to arginine in *BubR1* allele by homologous recombination-mediated knock-in method                                   *BubR1^K243R/K243R^*                                                                                                                                                     Embryonic lethal at E6.5 -Heterozygous mutants exhibit spontaneous tumorigenesis, one year after birth                                                                                                                  
  *BubR1^K243R/+^* *(K243R/+)*                                                                                                                               -Tumor incidence \>40%-No developmental defect-No aging phenotype-Massive chromosome mis-segregation due to impaired KT-MT attachment combined with weakened SAC         [@b38-molcell-37-10-713]                                                                                                                                                                                                
